IBRX · ImmunityBio, Inc.
$8.07
+0.58 (+7.67%)
At close · Jul 21
Going-concern doubt
— cleared May 7, 2026
The latest filing states the doubt was alleviated.
“As a result of continuing anticipated operating cash outflows as we commercialize our approved product and accelerate our development efforts, we believe that substantial doubt exists regarding our ability to continue as a going concern without additional funding or financial support. However, we believe our existing cash and cash equivalents, and investments in marketable securities; sales of our approved product; capital to be raised through equity offerings; and our potential ability to borrow from affiliated entities will be sufficient to fund our operations through at least the next 12 months following the issuance date of the condensed consolidated financial statements, including our Founder, Executive Chairman and Global Chief Scientific and Medical Officer's intent and ability to support our operations with additional funds, including loans from affiliated entities, as required, which we believe alleviates such doubt.”View the 10-Q filed May 7, 2026
Market Cap
$8.45B
Shares
1.05B
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
79/100
Short interest 12.6% of shares — P93
Days to cover 8.7 — P94
Price vs VWAP +2.6% — P67
Short-volume trend +6.7% — P75
Short interest change -2.5% — P38
Worst FTD 0.08% of shares — P72
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 131,830,884 | 135,149,785 | -3,318,901 | 8.66 |
| 2026-06-15 | 135,149,785 | 132,143,163 | +3,006,622 | 11.95 |
| 2026-05-29 | 132,143,163 | 132,753,919 | -610,756 | 7.64 |
| 2026-05-15 | 132,753,919 | 138,109,255 | -5,355,336 | 10.57 |
| 2026-04-30 | 138,109,255 | 140,326,066 | -2,216,811 | 10.60 |
| 2026-04-15 | 140,326,066 | 135,542,079 | +4,783,987 | 9.54 |
| 2026-03-31 | 135,542,079 | 134,199,301 | +1,342,778 | 4.68 |
| 2026-03-13 | 134,199,301 | 132,437,647 | +1,761,654 | 5.26 |
| 2026-02-27 | 132,437,647 | 134,701,658 | -2,264,011 | 2.68 |
| 2026-02-13 | 134,701,658 | 135,160,945 | -459,287 | 6.18 |
| 2026-01-30 | 135,160,945 | 127,000,990 | +8,159,955 | 1.69 |
| 2026-01-15 | 127,000,990 | 120,642,502 | +6,358,488 | 5.56 |
| 2025-12-31 | 120,642,502 | 109,024,436 | +11,618,066 | 8.27 |
| 2025-12-15 | 109,024,436 | 88,553,549 | +20,470,887 | 8.26 |
| 2025-11-28 | 88,553,549 | 81,064,526 | +7,489,023 | 8.44 |
| 2025-11-14 | 81,064,526 | 73,753,432 | +7,311,094 | 9.18 |
| 2025-10-31 | 73,753,432 | 72,564,054 | +1,189,378 | 8.49 |
| 2025-10-15 | 72,564,054 | 73,427,568 | -863,514 | 7.11 |
| 2025-09-30 | 73,427,568 | 84,559,728 | -11,132,160 | 7.91 |
| 2025-09-15 | 84,559,728 | 75,307,294 | +9,252,434 | 7.36 |
| 2025-08-29 | 75,307,294 | 75,175,215 | +132,079 | 9.19 |
| 2025-08-15 | 75,175,215 | 77,068,923 | -1,893,708 | 8.06 |
| 2025-07-31 | 77,068,923 | 76,978,537 | +90,386 | 8.99 |
Showing 1–23 of 23 settlements
Key facts
CIK
1326110
CUSIP
45256X103
13F (30d)
64 filings
64 filers
Visit website
Investor relations